Main menu

You are here

Treatments

Pfizer COVID tracking confirms safety for kids, heart issues extremely rare.

Fri, 2023-05-26 23:36 — mike kraft

Pfizer COVID vaccine tracking confirms safety in kids, with myocarditis, pericarditis rare CIDRAP

Monitoring of Pfizer/BioNTech COVID-19 vaccine safety among more than 3 million US children aged 5 to 17 years flagged just 2 of 20 health outcomes among 12- to 17-year-olds—myocarditis and pericarditis, which were rare.

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Read more about Pfizer COVID tracking confirms safety for kids, heart issues extremely rare.
Log in or register to post comments

EU, Pfizer/BioNTech agree to cut COVID vaccine purchases

Fri, 2023-05-26 23:29 — mike kraft

EU, Pfizer/BioNTech announce amendment to COVID vaccine contract The European Union and drugmakers Pfizer and BioNTech said on Friday they had reached a deal to amend a COVID-19 vaccine contract, cutting the number the EU must buy and pushing the delivery deadline to 2026. Maggie Fick Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about EU, Pfizer/BioNTech agree to cut COVID vaccine purchases
Log in or register to post comments

12 key symptoms define long Covid, new study shows, bringing treatments closer

Fri, 2023-05-26 04:47 — mike kraft

Government-funded study creates first symptom-based long Covid definition, a step toward finding treatments | CNN After more than two years and an investment of nearly $1.2 billion, researchers say they’ve come up with a list of 12 symptoms that can reliably classify someone as having long Covid, a working definition that should accelerate research into the disabling condition. CNN

Country / Region Tags:

General Topic Tags:

Public Attitudes

Problem, Solution, SitRep, or ?:

Situation Report

Read more about 12 key symptoms define long Covid, new study shows, bringing treatments closer
Log in or register to post comments

COVID pill Paxlovid gets full FDA approval after more than a year of emergency use

Fri, 2023-05-26 04:42 — mike kraft

COVID pill Paxlovid gets full FDA approval after more than a year of emergency use U.S. health regulators have given full approval to Pfizer’s COVID-19 pill Paxlovid. Thursday's action means the drug has now been fully vetted by the U.S. government and can remain on the market indefinitely. Millions of Americans have received Paxlovid since it was granted emergency authorization in late 2021. It’s become the go-to treatment for adults and older children. The FDA’s approval is only for adults who are at high risk of hospitalization or death from COVID-19. The drug is still available for children under emergency use. AP NEWS

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about COVID pill Paxlovid gets full FDA approval after more than a year of emergency use
Log in or register to post comments

Cognitive behavioral therapy reduces severe fatigue in long-COVID patients --Dutch study

Wed, 2023-05-10 07:25 — mike kraft

Cognitive behavioral therapy reduces severe fatigue in long-COVID patients Cognitive behavioral therapy lessens fatigue and improves concentration among long-COVID patients. CIDRAP

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Read more about Cognitive behavioral therapy reduces severe fatigue in long-COVID patients --Dutch study
Log in or register to post comments

China's CanSinoBIO's inhaled COVID booster reported stronger against BA.1 Omicron subvariant than Sinovac shot

Tue, 2023-05-09 22:21 — mike kraft

CanSinoBIO's inhaled COVID booster stronger against BA.1 Omicron subvariant than Sinovac shot Chinese vaccine firm CanSino Biologic's inhalation-based candidate elicited a better antibody response as a booster against the BA.1 Omicron sub-variant than Sinovac's shot, but the antibody level dropped in months, clinical trial data showed. Reuters R

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Testing

Problem, Solution, SitRep, or ?:

Opinion: The Covid-19 emergency is ending. It’s time for the patient to leave the hospital

Tue, 2023-05-09 22:06 — mike kraft

Dr. Sanjay Gupta: The Covid-19 emergency is ending. It's time for the patient to leave the hospital | CNN After more than three very long years, it's finally happening: The Covid-19 pandemic is ending, at least in the formal sense, both in this country and abroad. This moment is not being marked with parades or big parties but rather with the flourishes of two administrative pens. On Friday, the World Health Organization announced that Covid-19 no longer constitutes a Public Health Emergency of International Concern, and this Thursday, the United States is set to end its own public health emergency declaration. Dr.

Country / Region Tags:

General Topic Tags:

Medical Personnel

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Opinion: The Covid-19 emergency is ending. It’s time for the patient to leave the hospital
Log in or register to post comments

Analysis: Research into treating long COVID is stuck

Mon, 2023-05-08 21:42 — mike kraft

Long COVID Treatment Research Is Stuck in a Frustrating Catch-22 Patients are feeling abandoned, for good reason. Liz Highleyman Slate Magazine

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Read more about Analysis: Research into treating long COVID is stuck
Log in or register to post comments

Analysis: Failures in achieving COVID-19 vaccine equity

Sat, 2023-05-06 05:11 — mike kraft

Cascading failures in COVID-19 vaccine equity Ethical analysis should encompass upstream decisions and their downstream consequences Science

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Read more about Analysis: Failures in achieving COVID-19 vaccine equity
Log in or register to post comments

WHO releases strategy paper on COVID disease management and long-term disease prevention

Thu, 2023-05-04 22:55 — mike kraft

From emergency response to long-term COVID-19 disease management: sustaining gains made during the COVID-19 pandemic The updated two-year strategy builds on the objectives of the 2022 SPRP and supports countries as they are working to transition their critical emergency response activities to longer-term sustained COVID-19 disease prevention, control and management.

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Personnel

Social behavior

Problem, Solution, SitRep, or ?:

Read more about WHO releases strategy paper on COVID disease management and long-term disease prevention
Log in or register to post comments

Pages